| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40d8ddbdc8b9ada28098fd2152c69de3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate |
1985-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1989-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0e5dd1d4f9bc0ebe518ad6c39fbeb19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75f2082a27d15c498a51876e8b30d102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52199ba14fc02fdaf647db6b75f030a0 |
| publicationDate |
1989-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1259990-A |
| titleOfInvention |
Process for the preparation of thiadiazole derivatives active on the central nervous system |
| abstract |
PROCESS OR THE PREPARATION OF THIADIAZOLE DERIVATIVES ACTIVE ON THE CENTRAL NERVOUS SYSTEM ABSTRACT OF THE DISCLOSURE The invention relates to thiadiazole derivatives corresponding to the formula: in which R represents: - a linear or branched alkyl group having from 1 to 5 carbon atoms; - a cycloalkyl group having 5 or 6 carbon atoms; - a phenyl group optionally substituted by 1 or 2 halogen atoms, preferably chlorine, by 1 or 2 lower alkyl or lower alkoxy groups, by 1 or 2 hydroxyl groups or by a nitro or trifluoromethyl group; - a biphenylyl group; or - an alpha-naphthyl group; and pharmaceutically acceptable salts of the said derivatives. The said derivatives possess valuable therapeutic properties on the central nervous system. |
| priorityDate |
1984-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |